Subscribe to RSS
DOI: 10.5935/2526-8732.20200001
COVID-19 and surgical cancer care in Brazil
COVID-19 e tratamento cirúrgico do câncer no Brasil
Financial support: none to declare.
ABSTRACT
Concerned with the evolution of COVID-19 in Brazil and its impact on our health system and oncology surgical assistance, the authors performed a review and suggested strategies for approach based on current evidence.
RESUMO
Preocupados com a evolução do COVID-19 no Brasil e seu impacto em nosso sistema de saúde e assistência cirúrgica oncológica, os autores realizaram uma revisão e sugeriram estratégias de abordagem baseadas em evidências atuais.
Publication History
Received: 16 March 2020
Accepted: 20 March 2020
Article published online:
13 April 2020
© 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Rodrigo Nascimento Pinheiro, Alexandre Ferreira Oliveira, Heber Salvador de Castro Ribeiro, Reitan Ribeiro, Alberto J. A. Wainstein, Wilson Luiz da Costa. COVID-19 and surgical cancer care in Brazil. Brazilian Journal of Oncology 2020; 16: e-20200001.
DOI: 10.5935/2526-8732.20200001
-
REFERENCES
- Ministério da Saúde (BR), nstituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimate/2020 - Cancer incidence in Brazil [Internet]. Rio de Janeiro (RJ): INCA;; 2020. [cited 2020 Mar 09]; 1-122 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2020-incidencia-de-cancer-no-brasil.pdf
-
Wu Z,
McGoogan JM.
Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. . JAMA. 2020. Feb; 24; Epub ahead of print. https://doi.org/10.1001/jama.2020.2648
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R.. Features, evaluation and treatment coronavirus (COVID-19). Updated 2020 Mar 20 StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Jan; Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
-
Yang X,
Yu Y,
Xu J,
Shu H,
Xia J,
Liu H.
et al
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med. 2020. Feb; S2213-2600(20)30079-5. 2020 Feb 24. Epub ahead of print. https://doi.org/10.1016/S2213-2600(20)30079-5
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K. et al Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; Mar; 21 (03) 335-337 https://doi.org/10.1016/S1470-2045(20)30096-6
-
Xia Y,
Jin R,
Zhao J,
Li W,
Shen H.
Risk of COVID-19 for cancer patients. . Lancet Oncol. 2020. Mar; S1470-2045(20)30150-9. 2020 Mar; 3; Epub ahead of print https://doi.org/10.1016/S1470-2045(20)30150-9